Crescent Capital BDC, Inc. (NASDAQ:CCAP – Get Free Report)’s stock price hit a new 52-week low during mid-day trading on Monday . The company traded as low as $14.36 and last traded at $14.62, with a volume of 103339 shares trading hands. The stock had previously closed at $15.71.
Wall Street Analyst Weigh In
Separately, Wells Fargo & Company cut their target price on Crescent Capital BDC from $19.00 to $18.00 and set an “equal weight” rating for the company in a research note on Friday, February 21st. One analyst has rated the stock with a hold rating and four have given a buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $19.20.
View Our Latest Stock Analysis on CCAP
Crescent Capital BDC Trading Down 7.1 %
Crescent Capital BDC (NASDAQ:CCAP – Get Free Report) last posted its earnings results on Wednesday, February 19th. The company reported $0.55 earnings per share for the quarter, missing analysts’ consensus estimates of $0.56 by ($0.01). Crescent Capital BDC had a return on equity of 11.90% and a net margin of 37.32%. The company had revenue of $46.40 million for the quarter, compared to the consensus estimate of $47.27 million. On average, equities analysts predict that Crescent Capital BDC, Inc. will post 2.09 earnings per share for the current fiscal year.
Crescent Capital BDC Announces Dividend
The company also recently declared a dividend, which was paid on Friday, March 14th. Stockholders of record on Friday, February 28th were issued a dividend of $0.05 per share. The ex-dividend date of this dividend was Friday, February 28th. Crescent Capital BDC’s dividend payout ratio (DPR) is currently 84.42%.
Institutional Inflows and Outflows
A number of large investors have recently added to or reduced their stakes in CCAP. Franklin Resources Inc. increased its position in Crescent Capital BDC by 35.2% in the 3rd quarter. Franklin Resources Inc. now owns 256,279 shares of the company’s stock valued at $4,726,000 after acquiring an additional 66,713 shares during the period. Stifel Financial Corp lifted its stake in shares of Crescent Capital BDC by 53.1% in the third quarter. Stifel Financial Corp now owns 66,470 shares of the company’s stock worth $1,230,000 after acquiring an additional 23,055 shares during the period. Raymond James Financial Inc. bought a new stake in shares of Crescent Capital BDC in the 4th quarter valued at $3,750,000. Redhawk Wealth Advisors Inc. acquired a new stake in shares of Crescent Capital BDC during the fourth quarter worth $659,000. Finally, Oppenheimer & Co. Inc. bought a new position in Crescent Capital BDC during the fourth quarter worth $261,000. Institutional investors own 49.46% of the company’s stock.
Crescent Capital BDC Company Profile
Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.
Recommended Stories
- Five stocks we like better than Crescent Capital BDC
- What Are Treasury Bonds?
- NVIDIA Stock: Oversold, Undervalued — How Low Can It Go?
- Investing in Construction Stocks
- MicroStrategy Sees Insider Buy-Sell Action in Q1
- Overbought Stocks Explained: Should You Trade Them?
- These Dividend Stocks Might Be the Safest Bet Right Now
Receive News & Ratings for Crescent Capital BDC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Crescent Capital BDC and related companies with MarketBeat.com's FREE daily email newsletter.